{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T11:46:47Z","timestamp":1792583207750,"version":"4.5.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014039","name":"DOD Prostate Cancer Research Program","doi-asserted-by":"publisher","award":["Award W81XWH-17-1-0286"],"award-info":[{"award-number":["Award W81XWH-17-1-0286"]}],"id":[{"id":"10.13039\/100014039","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014039","name":"DOD Prostate Cancer Research Program","doi-asserted-by":"publisher","award":["W81XWH-17-1-0286"],"award-info":[{"award-number":["W81XWH-17-1-0286"]}],"id":[{"id":"10.13039\/100014039","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000892","name":"Prostate Cancer Foundation","doi-asserted-by":"publisher","award":["19CHAS03"],"award-info":[{"award-number":["19CHAS03"]}],"id":[{"id":"10.13039\/100000892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017062","name":"Johns Hopkins Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["R 01 1R01CA288760"],"award-info":[{"award-number":["R 01 1R01CA288760"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.modpat.2026.101065","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:34:41Z","timestamp":1786548881000},"page":"101065","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Subclonal Complete Loss of CDKN1B as a Common Genomic Alteration in Prostate Cancer: Associations With Race and Prostate Cancer Outcomes"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7015-3059","authenticated-orcid":false,"given":"Karen S.","family":"Sfanos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Morton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia N.","family":"Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca Y.","family":"Sosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Mummert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Hicks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara L.","family":"Lotan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuezhou","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Eshleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrine E.","family":"Joshu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo M.","family":"De Marzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.modpat.2026.101065_bib1","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1210\/me.2013-1039","article-title":"Minireview: the molecular and genomic basis for prostate cancer health disparities","volume":"27","author":"Powell","year":"2013","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.modpat.2026.101065_bib2","first-page":"290","article-title":"Cancer statistics for African Americans, 2016: progress and opportunities in reducing racial disparities","volume":"66","author":"DeSantis","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.modpat.2026.101065_bib3","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1158\/2159-8290.CD-16-0960","article-title":"Exome sequencing of African-American prostate cancer reveals loss-of-function ERF mutations","volume":"7","author":"Huang","year":"2017","journal-title":"Cancer Discov"},{"key":"10.1016\/j.modpat.2026.101065_bib4","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1158\/1078-0432.CCR-19-4112","article-title":"Genomic profiling of prostate cancers from men with African and European ancestry","volume":"26","author":"Koga","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.modpat.2026.101065_bib5","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1056\/NEJMc2000069","article-title":"Racial differences in genomic profiling of prostate cancer","volume":"383","author":"Mahal","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.modpat.2026.101065_bib6","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1158\/1055-9965.EPI-12-0042","article-title":"The TMPRSS2:ERG rearrangement, ERG expression, and prostate cancer outcomes: a cohort study and meta-analysis","volume":"21","author":"Pettersson","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.modpat.2026.101065_bib7","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/pros.21265","article-title":"TMPRSS2-ERG gene fusion prevalence and class are significantly different in prostate cancer of Caucasian, African-American and Japanese patients","volume":"71","author":"Magi-Galluzzi","year":"2011","journal-title":"Prostate"},{"key":"10.1016\/j.modpat.2026.101065_bib8","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.1158\/1078-0432.CCR-13-2265","article-title":"Evidence for molecular differences in prostate cancer between African American and Caucasian men","volume":"20","author":"Khani","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.modpat.2026.101065_bib9","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1158\/1078-0432.CCR-21-2577","article-title":"Differences in prostate cancer genomes by self-reported race: contributions of genetic ancestry, modifiable cancer risk factors, and clinical factors","volume":"28","author":"Stopsack","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.modpat.2026.101065_bib10","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.eururo.2016.07.026","article-title":"Prevalence and prognostic significance of PTEN loss in African-American and European-American men undergoing radical prostatectomy","volume":"71","author":"Tosoian","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.modpat.2026.101065_bib11","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1158\/1541-7786.MCR-20-0648","article-title":"Distinct genomic alterations in prostate tumors derived from African American men","volume":"18","author":"Liu","year":"2020","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.modpat.2026.101065_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1008641","article-title":"Integrative comparison of the genomic and transcriptomic landscape between prostate cancer patients of predominantly African or European genetic ancestry","volume":"16","author":"Yuan","year":"2020","journal-title":"PLoS Genet"},{"key":"10.1016\/j.modpat.2026.101065_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0241934","article-title":"GSTP1 positive prostatic adenocarcinomas are more common in Black than White men in the United States","volume":"16","author":"Vidal","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.modpat.2026.101065_bib14","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.ebiom.2015.10.028","article-title":"A novel genomic alteration of LSAMP associates with aggressive prostate cancer in African American men","volume":"2","author":"Petrovics","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.modpat.2026.101065_bib15","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1080\/15384101.2016.1157238","article-title":"The non-canonical functions of p27(Kip1) in normal and tumor biology","volume":"15","author":"Sharma","year":"2016","journal-title":"Cell Cycle"},{"key":"10.1016\/j.modpat.2026.101065_bib16","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/24179","article-title":"The murine gene p27Kip1 is haplo-insufficient for tumour suppression","volume":"396","author":"Fero","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.modpat.2026.101065_bib17","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nature11017","article-title":"The landscape of cancer genes and mutational processes in breast cancer","volume":"486","author":"Stephens","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.modpat.2026.101065_bib18","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/path.5584","article-title":"CDKN1B mutation and copy number variation are associated with tumor aggressiveness in luminal breast cancer","volume":"253","author":"Viotto","year":"2021","journal-title":"J Pathol"},{"key":"10.1016\/j.modpat.2026.101065_bib19","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/cr.2007.86","article-title":"p27: tumor suppressor and oncogene\u2026?","volume":"17","author":"Kossatz","year":"2007","journal-title":"Cell Res"},{"key":"10.1016\/j.modpat.2026.101065_bib20","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.cell.2018.02.060","article-title":"MC3 Working Group; Cancer Genome Atlas Research Network. Comprehensive characterization of cancer driver genes and mutations","volume":"173","author":"Bailey","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.modpat.2026.101065_bib21","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev.med.50.1.401","article-title":"The prognostic significance of altered cyclin-dependent kinase inhibitors in human cancer","volume":"50","author":"Tsihlias","year":"1999","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.modpat.2026.101065_bib22","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1101\/gad.1556607","article-title":"Discovery of an oncogenic activity in p27Kip1 that causes stem cell expansion and a multiple tumor phenotype","volume":"21","author":"Besson","year":"2007","journal-title":"Genes Dev"},{"key":"10.1016\/j.modpat.2026.101065_bib23","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1158\/0008-5472.CAN-05-3304","article-title":"Reduction of cytosolic p27(Kip1) inhibits cancer cell motility, survival, and tumorigenicity","volume":"66","author":"Wu","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.modpat.2026.101065_bib24","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0002-9440(10)65632-5","article-title":"Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells","volume":"153","author":"De Marzo","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1016\/j.modpat.2026.101065_bib25","first-page":"2269","article-title":"Loss of the cyclin-dependent kinase inhibitor p27(Kip1) protein in human prostate cancer correlates with tumor grade","volume":"3","author":"Guo","year":"1997","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.modpat.2026.101065_bib26","first-page":"542","article-title":"Loss of cyclin-dependent kinase inhibitor p27Kip1 is a novel prognostic factor in localized human prostate adenocarcinoma","volume":"58","author":"Tsihlias","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.modpat.2026.101065_bib27","doi-asserted-by":"crossref","first-page":"27966","DOI":"10.18632\/oncotarget.4626","article-title":"Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer","volume":"6","author":"Kluth","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.modpat.2026.101065_bib28","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.humpath.2010.10.006","article-title":"Subcellular localization of p27 and prostate cancer recurrence: automated digital microscopy analysis of tissue microarrays","volume":"42","author":"Ananthanarayanan","year":"2011","journal-title":"Hum Pathol"},{"key":"10.1016\/j.modpat.2026.101065_bib29","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1093\/jnci\/90.17.1284","article-title":"Distinct altered patterns of p27KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma","volume":"90","author":"Cordon-Cardo","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.modpat.2026.101065_bib30","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0022-5347(01)63776-5","article-title":"Low p27 expression predicts poor disease-free survival in patients with prostate cancer","volume":"159","author":"Yang","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.modpat.2026.101065_bib31","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/sj.bjc.6690806","article-title":"Predictive value of decreased p27Kip1 protein expression for the recurrence-free and long-term survival of prostate cancer patients","volume":"81","author":"Kuczyk","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1016\/j.modpat.2026.101065_bib32","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/84879","article-title":"Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse","volume":"27","author":"Di Cristofano","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.modpat.2026.101065_bib33","first-page":"1474","article-title":"Combined loss of PTEN and p27 expression is associated with tumor cell proliferation by Ki-67 and increased risk of recurrent disease in localized prostate cancer","volume":"9","author":"Halvorsen","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.modpat.2026.101065_bib34","first-page":"5652","article-title":"Identification of 12p as a region of frequent deletion in advanced prostate cancer","volume":"58","author":"Kibel","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.modpat.2026.101065_bib35","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.cell.2018.06.039","article-title":"Genomic hallmarks and structural variation in metastatic prostate cancer","volume":"174","author":"Quigley","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.modpat.2026.101065_bib36","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.annonc.2021.03.205","article-title":"Cabazitaxel versus abiraterone or enzalutamide in poor prognosis metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase II trial","volume":"32","author":"Annala","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.modpat.2026.101065_bib37","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djx118","article-title":"Concordance of circulating tumor DNA and matched metastatic tissue biopsy in prostate cancer","volume":"109","author":"Wyatt","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.modpat.2026.101065_bib38","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1158\/1078-0432.CCR-19-1669","article-title":"CDKN1B deletions are associated with metastasis in African American men with clinically localized, surgically treated prostate cancer","volume":"26","author":"Faisal","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.modpat.2026.101065_bib39","doi-asserted-by":"crossref","DOI":"10.1200\/PO.17.00029","article-title":"Prospective genomic profiling of prostate cancer across disease states reveals germline and somatic alterations that may affect clinical decision making","author":"Abida","year":"2017","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.modpat.2026.101065_bib40","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.cell.2015.05.001","article-title":"Integrative clinical genomics of advanced prostate cancer","volume":"161","author":"Robinson","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.modpat.2026.101065_bib41","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41588-018-0078-z","article-title":"The long tail of oncogenic drivers in prostate cancer","volume":"50","author":"Armenia","year":"2018","journal-title":"Nat Genet"},{"key":"10.1016\/j.modpat.2026.101065_bib42","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ccr.2010.05.026","article-title":"Integrative genomic profiling of human prostate cancer","volume":"18","author":"Taylor","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.modpat.2026.101065_bib43","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/path.5815","article-title":"P2X4 purinergic receptors offer a therapeutic target for aggressive prostate cancer","volume":"256","author":"Maynard","year":"2022","journal-title":"J Pathol"},{"key":"10.1016\/j.modpat.2026.101065_bib44","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1053\/hupa.2002.126187","article-title":"Inadequate formalin fixation decreases reliability of p27 immunohistochemical staining: probing optimal fixation time using high-density tissue microarrays","volume":"33","author":"De Marzo","year":"2002","journal-title":"Hum Pathol"},{"key":"10.1016\/j.modpat.2026.101065_bib45","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.humpath.2019.02.006","article-title":"TP53 missense mutation is associated with increased tumor-infiltrating T cells in primary prostate cancer","volume":"87","author":"Kaur","year":"2019","journal-title":"Hum Pathol"},{"key":"10.1016\/j.modpat.2026.101065_bib46","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1038\/s41379-018-0083-x","article-title":"Association of tumor-infiltrating T-cell density with molecular subtype, racial ancestry and clinical outcomes in prostate cancer","volume":"31","author":"Kaur","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.modpat.2026.101065_bib47","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"key":"10.1016\/j.modpat.2026.101065_bib48","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1002\/cncr.34190","article-title":"Association of B7-H3 expression with racial ancestry, immune cell density, and androgen receptor activation in prostate cancer","volume":"128","author":"Mendes","year":"2022","journal-title":"Cancer"},{"key":"10.1016\/j.modpat.2026.101065_bib49","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1158\/1055-9965.EPI-19-0962","article-title":"High extratumoral mast cell counts are associated with a higher risk of adverse prostate cancer outcomes","volume":"29","author":"Hempel Sullivan","year":"2020","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.modpat.2026.101065_bib50","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/pros.24424","article-title":"Localization of macrophage subtypes and neutrophils in the prostate tumor microenvironment and their association with prostate cancer racial disparities","volume":"82","author":"Maynard","year":"2022","journal-title":"Prostate"},{"key":"10.1016\/j.modpat.2026.101065_bib51","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/jnci\/90.10.756","article-title":"Clinical characteristics and biopsy specimen features in African-American and white men without prostate cancer","volume":"90","author":"Eastham","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.modpat.2026.101065_bib52","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1158\/1055-9965.EPI-12-1238","article-title":"Genes associated with prostate cancer are differentially expressed in African American and European American men","volume":"22","author":"Powell","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"Suppl 1","key":"10.1016\/j.modpat.2026.101065_bib53","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/1750-9378-4-S1-S3","article-title":"Microarray comparison of prostate tumor gene expression in African-American and Caucasian American males: a pilot project study","volume":"4","author":"Reams","year":"2009","journal-title":"Infect Agent Cancer"},{"key":"10.1016\/j.modpat.2026.101065_bib54","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1158\/0008-5472.CAN-07-2608","article-title":"Tumor immunobiological differences in prostate cancer between African-American and European-American men","volume":"68","author":"Wallace","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.modpat.2026.101065_bib55","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.2217\/pgs-2016-0025","article-title":"Systems analysis of the prostate transcriptome in African-American men compared with European-American men","volume":"17","author":"Hardiman","year":"2016","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.modpat.2026.101065_bib56","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41391-018-0093-2","article-title":"PTEN status assessment in the Johns Hopkins active surveillance cohort","volume":"22","author":"Tosoian","year":"2019","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.modpat.2026.101065_bib57","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.3390\/cancers17172862","article-title":"Prognostic significance of PTEN loss in prostate cancer: a meta-analysis of Gleason grade and clinical outcomes","volume":"17","author":"Kisiel","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.modpat.2026.101065_bib58","doi-asserted-by":"crossref","first-page":"6563","DOI":"10.1158\/1078-0432.CCR-11-1244","article-title":"PTEN protein loss by immunostaining: analytic validation and prognostic indicator for a high risk surgical cohort of prostate cancer patients","volume":"17","author":"Lotan","year":"2011","journal-title":"Clin Cancer Res"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395226001080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395226001080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T11:30:54Z","timestamp":1792582254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395226001080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":58,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0893395226001080"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2026.101065","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subclonal Complete Loss of CDKN1B as a Common Genomic Alteration in Prostate Cancer: Associations With Race and Prostate Cancer Outcomes","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2026.101065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 THE AUTHORS. Published by Elsevier Inc. on behalf of the United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}],"article-number":"101065"}}